"post-infection, parainfectious, or post-vaccination (e.g. ADEM)"
"post-infection, parainfectious, or post-vaccination (e.g. ADEM)"
"T1: isointense or hypointense"
"T2: poorly delineated hyperintense signal"
"T1 C+ (Gd): variable enhancement patterns (none, diffuse, patchy, peripheral)"
"As the diagnosis does not have a sensitive and specific laboratory test, histology is usually not obtained, particularly as biopsy of the spinal cord has a high morbidity. Imaging features overlap with other inflammatory and neoplastic entities. A set of diagnostic criteria have been proposed by the Transverse Myelitis Consortium Working Group 7:"
"post-infection, parainfectious, or post-vaccination (e.g. ADEM)"
"The incidence of acute transverse myelitis is 1-4 cases per million people per year 7. It affects individuals of all ages with peaks at ages 10-19 years and 30-39 years 7. There is no sex or familial predisposition and usually no prior history of neurologic abnormality."
"exclusion of extra-axial compression by neuroimaging (MRI or myelography; CT is not adequate)"
"post-infection, parainfectious, or post-vaccination (e.g. ADEM)"
"connective tissue disease (e.g. systemic lupus erythematosus, rheumatoid arthritis, Sjögren disease, antiphospholipid syndrome)"
"systemic malignancy (e.g. paraneoplastic)"